OncoImmune's Series A Round

OncoImmune raised a round of funding on January 12, 2017. Investors include 3E Bioventures.

OncoImmune is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune dise…

Articles about OncoImmune's Series A Round: